WB
VKTX icon

WesBanco Bank’s Viking Therapeutics VKTX Stock Holding History

WesBanco Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Hold
52,000
– – 0.05% 261
2026
Q1 		$1.69M Hold
52,000
– – 0.05% 269
2025
Q4 		$1.83M Hold
52,000
– – 0.05% 253
2025
Q3 		$1.37M Hold
52,000
– – 0.04% 320
2025
Q2 		$1.38M Buy
52,000
+28,200
+118% +$742K 0.04% 304
2025
Q1 		$575K Buy
23,800
+12,000
+102% +$379K 0.02% 405
2024
Q4 		$475K Buy
+11,800
New +$673K 0.02% 442

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

WesBanco Bank's VKTX Position: Q2 2026 in Review

WesBanco Bank held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 52,000 shares worth $2.03M. The position accounts for 0.05% of the portfolio, ranked #261.

WesBanco Bank first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • WesBanco Bank held 52,000 shares of Viking Therapeutics worth $2.03M as of Q2 2026.
  • WesBanco Bank left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #261 holding.
  • WesBanco Bank first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.